ELU001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ELU001, covering 2024-08-07 to 2024-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) [Phase 1, Phase 2]